IMI’s EHDEN is developing a federated data network at scale across Europe, to reduce the time to provide key answers to health research in the real world. The challenge is how can a federated data model help HTAs determine value for patients and healthcare systems? 

In this podcast we discuss these challenges with Jacoline Bouvy, who co-leads EHDEN’s work package 2, focused on outcome driven healthcare. It will outline many of the core challenges that HTA’s face harnessing federated datasets, and outline several issues to be discussed in a multi-stakeholder webinar to be held on October 22nd. 

Jacoline is the Senior Scientific Adviser for Science Policy and Research at the National Institute for Health and Care Excellence (NICE), based in London. Jacoline is a Dutch health economist specialising in the interface between marketing authorisation and health technology assessment (HTA) of drugs. She’s been involved in several pan-European IMI projects: ADAPT-SMART, ROADMAP, Neuronet and EHDEN.

IMI’s EHDEN is developing a federated data network at scale across Europe, to reduce the time to provide key answers to health research in the real world. The challenge is how can a federated data model help HTAs determine value for patients and healthcare systems? In this podcast we discuss these challenges with Jacoline Bouvy, who co-leads EHDEN’s work package 2, focused on outcome driven healthcare. It will outline many of the core challenges that HTA’s face harnessing federated datasets, and outline several issues to be discussed in a multi-stakeholder webinar to be held on October 22nd. Jacoline is the Senior Scientific Adviser for Science Policy and Research at the National Institute for Health and Care Excellence (NICE), based in London. Jacoline is a Dutch health economist specialising in the interface between marketing authorisation and health technology assessment (HTA) of drugs. She’s been involved in several pan-European IMI projects: ADAPT-SMART, ROADMAP, Neuronet and EHDEN.

Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast.  Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.

Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast.  Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.

Duane Schulthess, Managing Director of Vital Tran…

Vital Health Podcast

IMI’s EHDEN is developing a federated data networ…

Advertisement